DAWNZERA
Live / Applied — Statement of use — registration review complete (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 05 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98027559
- Mark type
- Stylized text
- Filed
- 05 Jun 2023
- Published for opposition
- 21 Nov 2023
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 31 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Sept 2025 — USE AMENDMENT FILED
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Jul 2025 — SOU EXTENSION 3 FILED
- 10 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS